July 2026 in “Mendeley Data” The systematic review titled "Dupilumab's Bidirectional Effects on Alopecia Areata" analyzed data from 56 studies involving 109 patients to assess the effects of dupilumab on alopecia areata. The review included variables such as patient demographics, alopecia areata subtype and severity, treatment regimens, and clinical outcomes. The findings highlighted that dupilumab can have bidirectional effects, meaning it may lead to either hair regrowth or hair loss in patients with alopecia areata. The study utilized Severity of Alopecia Tool (SALT) scores and considered concomitant therapies and follow-up durations to provide a comprehensive analysis of dupilumab's impact on this condition.
4 citations
,
May 2025 in “Journal of the American Academy of Dermatology”
2 citations
,
June 2022 in “Journal of cosmetic dermatology” Dupilumab can help hair regrowth but may also trigger alopecia areata.
29 citations
,
July 2019 in “Dermatologic Therapy” Dupilumab can both heal and cause hair loss.
10 citations
,
October 2024 in “Dermatology Practical & Conceptual” Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.